Firm commits to fight hypertension, CVDs, NCDs in Africa

A global, science-led biopharmaceutical company, AstraZeneca through its innovative programme, Healthy Heart Africa (HHA), has reiterated it commitment in tackling hypertension and the rising burden of cardiovascular diseases (CVDs) and Non-Communicable Diseases (NCDs) in Africa. According to the World Health